Surgical, N-95 Masks Can Reduce Covid-19 Cough-Cloud By 7, 23 Times: IIT-Bombay Study

Mumbai : Surgical and N-95 masks can reduce the volume of a coronavirus disease (Covid-19)–laden cough-cloud by seven and 23 times, respectively, according to a recent study conducted by two scientists from the Indian Institute of Technology (IIT) – Bombay.

The study, which was published in a journal by the American Institute of Physics on Tuesday, sets out to estimate the volume of air contaminated by the cough of a Covid-19 patient.

Professors Amit Agrawal and Rajneesh Bharadwaj, who are attached to IIT-Bombay’s department of mechanical engineering, has conducted the study.

The findings have revealed that up to eight seconds after a Covid-19 patient coughs held the key, as suspended exhaled droplets permeate the air, where the level of the viral infection is likely to go up by 23 times.

“The presence of a mask drastically reduces the volume and significantly cuts down the risk of the viral infection for other persons present in a room. Similarly, actions such as coughing into the elbow and the use of a handkerchief can reduce the volume of a cough cloud and, consequently, the chances of dispersion of the virus,” the study stated.

The researchers had set out to analyse the volume, temperature, and relative humidity of the cloud produced by coughing to understand their dispersion in the surrounding air.

They had used a mathematical model to analyse the fluid dynamics and thermodynamics of the cough cloud. They found that the cough cloud lasted between five and 14 seconds following which it would dissipate.

“An N-95 mask not only cuts down the number of droplets exhaled by a Covid-19 patient, but also reduces the amount of infected air produced by the person,” said the researchers.

They exuded confidence that the findings would help understand how SARS-CoV2, which causes Covid-19, spreads in the air.

Related Posts

WHO launches new primary health care course to strengthen health systems globally

Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A